The mosquito species Anopheles gambiae is a major carrier of dangerous malaria parasites in sub-Saharan Africa, where 90 per cent of annual malaria deaths occur. Malaria infects more than 200 million people each year and causes more than 430,000 deaths.
Now, a team of researchers led by Imperial College London have genetically modified Anopheles gambiae so that they carry a modified gene disrupting egg production in female mosquitoes. They used a technology called ‘gene drive’ to ensure the gene is passed down at an accelerated rate to offspring, spreading the gene through a population over time.
Within a few years, the spread could drastically reduce or eliminate local populations of the malaria-carrying mosquito species. Their findings represent an important step forward in the ability to develop novel methods of vector control.
Normally, each gene variant has a 50 per cent chance of being passed down from parents to their offspring. In the Imperial team’s experiments with Anopheles gambiae, the gene for infertility was transmitted to more than 90 per cent of both male and female mosquitoes’ offspring.
The technique uses recessive genes, so that many mosquitoes will inherit only one copy of the gene. Two copies are needed to cause infertility, meaning that mosquitoes with only one copy are carriers, and can spread the gene through a population.
This is the first time the technique has been demonstrated inAnopheles gambiae. The team targeted three different fertility genes and tested each for their suitability for affecting a mosquito population through gene drive, demonstrating the strength and flexibility of the technique to be applied to a range of genes. The results are published today in the journal Nature Biotechnology.
“The field has been trying to tackle malaria for more than 100 years. If successful, this technology has the potential to substantially reduce the transmission of malaria,” said co-author Professor Andrea Crisanti from the Department of Life Sciences at Imperial.
“As with any new technology, there are many more steps we will go through to test and ensure the safety of the approach we are pursuing. It will be at least 10 more years before gene drive malaria mosquitos could be a working intervention,” added Professor Austin Burt from Imperial’s Department of Life Sciences.
The Latest on: Gene drive
via Google News
The Latest on: Gene drive
- Inhibitor of KRAS gene mutation shows promise in lung, bowel and other solid tumorson October 25, 2020 at 11:04 am
New results from early clinical trials of a drug that targets a cancer-causing mutation in the KRAS gene have shown that it can shrink tumours and is well-tolerated by patients.
- Police: 13-year-old dies in Louisville crash on Gene Snyder, several others injuredon October 25, 2020 at 6:15 am
LOUISVILLE, Ky. — A 13-year-old was killed and multiple other people were injured in a crash on Gene Snyder Freeway Saturday evening, according to a statement from the Louisville Metro Police ...
- Sana CEO reveals details about stealthy gene therapy startup that has raised more than $700Mon October 23, 2020 at 4:15 pm
Sana Biotechnology CEO Steve Harr shed more light on one of most secretive, heavily funded startups in Seattle and the global biotech industry — detailing its plans to create tools that replace ...
- Kiss frontman Gene Simmons lists Beverly Hills mansion for $22Mon October 23, 2020 at 11:03 am
Simmons and his wife, model Sharon Tweed, first moved into 2650 Benedict Canyon Drive in 1984 after buying it for $1.35 million. At 16,000 square feet, the Beverly Hills estate fits the bill for even ...
- Ultragenyx and Solid Biosciences Announce Strategic Collaboration to Develop and Commercialize New Gene Therapies for Duchenne Muscular Dystrophyon October 23, 2020 at 5:06 am
Collaboration combines Solid’s differentiated microdystrophin construct and Ultragenyx’s HeLa PCL manufacturing platform for use with AAV8 and variants- -Solid receives $40 million upfront via equity ...
- What do you call a city on the verge of cell-and-gene stardom? Here are Philly's nomineeson October 22, 2020 at 9:02 am
Philadelphia is making a name for itself in the cell and gene therapy industry, but what should that name be? A pair of clever monikers have been put forth already.
- AVROBIO Appoints Dr. Gail Farfel to its Board of Directorson October 21, 2020 at 6:21 am
AVROBIO, Inc. (Nasdaq: AVRO), a leading clinical-stage gene therapy company with a mission to free people from a lifetime of genetic disease, today announced the appointment of Gail M. Farfel, Ph.D., ...
- H-ABC Foundation partners with UMass Medical School and Yale to study gene therapy for H-ABCon October 20, 2020 at 9:01 am
ABC has announced sponsored research agreements with UMass Medical School and Yale University to advance a targeted gene therapy for this rare degenerative children's disease. Guangping Gao, PhD, is ...
- What is the BRCA gene and should you get tested for it?on October 20, 2020 at 4:00 am
A gene mutation is an alteration in a person’s DNA pattern that puts them at a higher risk for certain diseases. There are 10 genes that increase a woman’s risk of breast cancer. The two most common ...
- The Italian Job: An Interview with Gene Therapist Federico Mingozzion October 19, 2020 at 1:49 pm
The Chief Scientific Officer of Spark Therapeutics, Federico Mingozzi, surveys the hopes and challenges facing the human gene therapy community.
via Bing News